SecBot SecBot
144 ·Filed Aug 7, 2026

TWST

Twist Bioscience Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed3mo ago SEC0001959173-26-005735
Actionable Insight • Neutral

This is a routine pre-planned director sale with no material signal for the stock. Monitor for any acceleration of insider selling or changes in insider sentiment, but this filing alone does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$115.67
T+0 close · Aug 7, 2026 · via day close
Latest settled
+32.08%
T+60 · $152.78
Vs SPY
+34.35%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 7 $115.67entry
  2. T+1 · 3mo ago +7.96%α +7.99% · $124.88
  3. T+5 · 3mo ago +2.51%α +2.11% · $118.57
  4. T+20 · 2mo ago +7.82%α +8.22% · $124.72
  5. T+60 · 15d ago +32.08%α +34.35% · $152.78
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Robert Chess filed a Form 144 notice to sell 18,417 shares of Twist Bioscience common stock, valued at approximately $2.04 million, pursuant to a 10b5-1 plan adopted on May 8, 2026. The sale is tied to a stock option exercise and represents a routine, pre-planned transaction by a director.

Key Facts

  • Director Robert Chess intends to sell 18,417 shares of TWST common stock.
  • Estimated market value of the proposed sale is $2,042,261.13.
  • Sale is related to a stock option exercise on August 7, 2026.
  • The 10b5-1 trading plan was adopted on May 8, 2026.
  • Shares represent approximately 0.03% of TWST's $6.8B market cap.

Financial Impact

Proposed sale of ~$2.04M, or ~0.03% of market cap.

dilution

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (TWST), Batch item 10001959173-26-005735
Document: 0001959173-26-005735-index.html0001959173-26-005735
Document: 0001959173-26-005735.txt0001959173-26-005735
144 Filing (TWST), Batch item 40001959173-26-005735
Document: 0001959173-26-005735-index.html0001959173-26-005735
Document: 0001959173-26-005735.txt0001959173-26-005735

Track record

47 reports on TWST

Performance horizon

8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
  2. Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
  3. Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
  4. Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
  5. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
  6. Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  7. Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
  8. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
  9. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
  10. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
Showing 10 of 47

US Market Status

Market Closed · Opens Wed (13h 20m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 7, 2026